Stromal cell-induced immune regulation in a transplantable lymphoid-like cell constructs

Biomaterials

Volumn 31, Issue 35, 2010, Pages 9273-9284

  Kaminer Israeli, Yael ^a   Shapiro, Jenny ^a   Cohen, Smadar ^a   Monsonego, Alon ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Alginate scaffold; Dendritic cells; Immune regulation; Stromal cells

Indexed keywords

ALGINATE SCAFFOLDS; AUTOIMMUNE DISEASE; CELL CONSTRUCTS; CELL INJECTION; CELL TRANSPLANTATION; CELL-BASED; DENDRITIC CELLS; IMMUNE REGULATION; IN-CELL; IN-VITRO; IN-VIVO; KIDNEY CAPSULES; LIPOPOLYSACCHARIDES; MATRIX; SIDE EFFECT; STROMAL CELLS; T CELLS;

ALGINATE; CYTOLOGY; LAWS AND LEGISLATION; SCAFFOLDS;

CELLS;

ALGINIC ACID; ENCEPHALITOGENIC PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEOLIPID PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CELL MATURATION; CELL MIGRATION; CELL TRANSPLANTATION; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CAPSULE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; MICROENVIRONMENT; MOUSE; NANOFABRICATION; NONHUMAN; PRIORITY JOURNAL; STROMA CELL;

ALGINATES; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; GLUCURONIC ACID; HEXURONIC ACIDS; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MICE; MYELIN PROTEOLIPID PROTEIN; STROMAL CELLS; TISSUE SCAFFOLDS;

MUS;

EID: 77957934908     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.08.070     Document Type: Article

References (51)

1. Jonuleit H., Adema G., Schmitt E. Immune regulation by regulatory T cells: implications for transplantation. Transpl Immunol 2003, 11:267-276.
2. Tarbell K.V., Petit L., Zuo X., Toy P., Luo X., Mqadmi A., et al. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 2007, 204:191-201.
3. Pan P.Y., Ozao J., Zhou Z., Chen S.H. Advancements in immune tolerance. Adv Drug Deliv Rev 2008, 60:91-105.
4. Wu K., Liu Y.L., Cui B., Han Z. Application of stem cells for cardiovascular grafts tissue engineering. Transpl Immunol 2006, 16:1-7.
5. Okamoto N., Chihara R., Shimizu C., Nishimoto S., Watanabe T. Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice. J Clin Invest 2007, 117:997-1007.
6. Suematsu S., Watanabe T. Generation of a synthetic lymphoid tissue-like organoid in mice. Nat Biotechnol 2004, 22:1539-1545.
7. Stachowiak A.N., Irvine D.J. Inverse opal hydrogel-collagen composite scaffolds as a supportive microenvironment for immune cell migration. J Biomed Mater Res A 2008, 85:815-828.
8. Ali O.A., Huebsch N., Cao L., Dranoff G., Mooney D.J. Inf0ection-mimicking materials to program dendritic cells in situ. Nat Mater 2009, 8:151-158.
9. Hori Y., Winans A.M., Huang C.C., Horrigan E.M., Irvine D.J. Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy. Biomaterials 2008, 29:3671-3682.
10. Leor J., Aboulafia-Etzion S., Dar A., Shapiro L., Barbash I.M., Battler A., et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?. Circulation 2000, 102:III56-61.
11. Perets A., Baruch Y., Weisbuch F., Shoshany G., Neufeld G., Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A 2003, 65:489-497.
12. Kedem A., Perets A., Gamlieli-Bonshtein I., Dvir-Ginzberg M., Mizrahi S., Cohen S. Vascular endothelial growth factor-releasing scaffolds enhance vascularization and engraftment of hepatocytes transplanted on liver lobes. Tissue Eng 2005, 11:715-722.
13. Dvir T., Kedem A., Ruvinov E., Levy O., Freeman I., Landa N., et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A 2009, 106:14990-14995.
14. Shapiro L., Cohen S. Novel alginate sponges for cell culture and transplantation. Biomaterials 1997, 18:583-590.
15. Hirata S., Matsuyoshi H., Fukuma D., Kurisaki A., Uemura Y., Nishimura Y., et al. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL. J Immunol 2007, 178:918-925.
16. Dennis J.E., Charbord P. Origin and differentiation of human and murine stroma. Stem Cells 2002, 20:205-214.
17. Parekkadan B., Tilles A.W., Yarmush M.L. Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells 2008, 26:1913-1919.
18. Uccelli A., Moretta L., Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 2006, 36:2566-2573.
19. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
20. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003, 101:3722-3729.
21. Klyushnenkova E., Mosca J.D., Zernetkina V., Majumdar M.K., Beggs K.J., Simonetti D.W., et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 2005, 12:47-57.
22. Sotiropoulou P.A., Perez S.A., Gritzapis A.D., Baxevanis C.N., Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006, 24:74-85.
23. Corcione A., Benvenuto F., Ferretti E., Giunti D., Cappiello V., Cazzanti F., et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006, 107:367-372.
24. Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005, 105:2214-2219.
25. Jiang X.X., Zhang Y., Liu B., Zhang S.X., Wu Y., Yu X.D., et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005, 105:4120-4126.
26. Le Blanc K., Rasmusson I., Sundberg B. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363:1439-1441.
27. Li H., Guo Z., Jiang X., Zhu H., Li X., Mao N. Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease. Stem Cells 2008, 26:2531-2541.
28. Djouad F., Plence P., Bony C., Tropel P., Apparailly F., Sany J., et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003, 102:3837-3844.
29. Bergfeld SA, DeClerck YA. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev;29:249-61.
30. Jones S., Horwood N., Cope A., Dazzi F. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol 2007, 179:2824-2831.
31. Haniffa M.A., Wang X.N., Holtick U., Rae M., Isaacs J.D., Dickinson A.M., et al. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 2007, 179:1595-1604.
32. Waldner H., Whitters M.J., Sobel R.A., Collins M., Kuchroo V.K. Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc Natl Acad Sci U S A 2000, 97:3412-3417.
33. Zipori D. Handbook of the hemopoietic microenvironment 1989, Human Press, Inc., Clifon, NJ.
34. Re'em T., Tsur-Gang O., Cohen S. The effect of immobilized RGD peptide in macroporous alginate scaffolds on TGFbeta1-induced chondrogenesis of human mesenchymal stem cells. Biomaterials 2010, 31:6746-6755.
35. Freeman I., Kedem A., Cohen S. The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 2008, 29:3260-3268.
36. Garrigan K., Moroni-Rawson P., McMurray C., Hermans I., Abernethy N., Watson J., et al. Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. Blood 1996, 88:3508-3512.
37. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992, 176:1693-1702.
38. Taube R., Zhu Q., Xu C., Diaz-Griffero F., Sui J., Kamau E., et al. Lentivirus display: stable expression of human antibodies on the surface of human cells and virus particles. PLoS One 2008, 3:e3181.
39. Freeman I., Cohen S. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 2009, 30:2122-2131.
40. Pappu B.P., Dong C. Measurement of interleukin-17. Curr Protoc Immunol 2007, [Chapter 6:Unit 6 25].
41. Dvir-Ginzberg M., Elkayam T., Cohen S. Induced differentiation and maturation of newborn liver cells into functional hepatic tissue in macroporous alginate scaffolds. Faseb J 2008, 22:1440-1449.
42. Gretz J.E., Anderson A.O., Shaw S. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol Rev 1997, 156:11-24.
43. Glicklis R., Shapiro L., Agbaria R., Merchuk J.C., Cohen S. Hepatocyte behavior within three-dimensional porous alginate scaffolds. Biotechnol Bioeng 2000, 67:344-353.
44. Dvir T., T-G O., Cohen Smadar " Designer" scaffolds for tissue engineering and regeneration. Isr J Chem 2005, 45:487-494.
45. Wrenshall L. Role of the microenvironment in immune responses to transplantation. Springer Semin Immunopathol 2003, 25:199-213.
46. Ruvinov E, Leor J, Cohen S. The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials;31:4573-82.
47. Zipori D., Toledo J., von der Mark K. Phenotypic heterogeneity among stromal cell lines from mouse bone marrow disclosed in their extracellular matrix composition and interactions with normal and leukemic cells. Blood 1985, 66:447-455.
48. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
49. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
50. Liu X.J., Zhang J.F., Sun B., Peng H.S., Kong Q.F., Bai S.S., et al. Reciprocal effect of mesenchymal stem cell on experimental autoimmune encephalomyelitis is mediated by transforming growth factor-beta and interleukin-6. Clin Exp Immunol 2009, 158:37-44.
51. Sallusto F., Mackay C.R., Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000, 18:593-620.